Barclays’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Barclays’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-600	Closed	-$37K	–	4865
2021 Q2	$37K	Buy	+600	New	+$36.5K	﹤0.01%	4272
2014 Q2	–	Sell	-663	Closed	-$28K	–	7688
2014 Q1	$28K	Sell	663 -780	-54%	-$32.7K	﹤0.01%	6409
2013 Q4	$58K	Hold	1,443	–	–	﹤0.01%	6081
2013 Q3	$51K	Sell	1,443 -615	-30%	-$21.7K	﹤0.01%	6051
2013 Q2	$68K	Buy	+2,058	New	+$68.4K	﹤0.01%	6085

Other funds holding IHE

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Barclays's IHE Position: Q3 2021 in Review

Barclays sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2021, closing a stake of 600 shares — an estimated $37K sold.

Barclays first reported a position in IHE in Q2 2013 and held it in 5 quarters. The position peaked at $68K in Q2 2013. 110 funds tracked by Wall St. Rank hold IHE as of Q3 2021.

Barclays reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2021 after selling out during the quarter.
Barclays sold 600 iShares US Pharmaceuticals ETF shares in Q3 2021, an estimated $37K.
Barclays first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 5 quarters.
Barclays's iShares US Pharmaceuticals ETF position peaked at $68K in Q2 2013.
110 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2021.

Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.